KYNB

NasdaqGSHealthcare

KYNTRA BIO, INC.

Latest filing · 2026-05-14 · scanner 12d behind

$0.0000

0.0%· 24h

Score

/ 100

Watching

4 triggers firing

C-suite buyFirst buy 12moSmall floatDays to cover

Market cap

$28.40M

Float

3.6M

88% of total

Shares out

4,048,112

Short % float

••••

Pro only

Days to cover

••••

Pro only

No price data yet — the yfinance scanner hasn't produced bars for KYNB.

AI briefPro — synthesised analysis of insider signals and filing context.

Upgrade →

Rule breakdown45 / 110 pts max

41% of maximum scoreSignalContext

Form 4 signals

Cluster buy

3+ distinct insiders with open-market buys in the last 30 days

–

pts

C-suite buy

CEO, CFO, Chair, or President made an open-market purchase

Wettig Thane — CEO

+20

pts

Large single buy

One open-market purchase exceeded the dollar threshold

–

pts

First buy in 12 months

An insider bought for the first time in the trailing 12 months

Wettig Thane

+15

pts

Net buying (90d)

Net (buys − sells) USD over the last 90 days is positive

–

pts

Context amplifiers

High short interest

Short interest as % of float exceeds the squeeze threshold

–

pts

Small float

Float is below the threshold — amplifies any accumulation signal

3.6M shares

pts

High days-to-cover

DTC > threshold — shorts can't exit cleanly on a squeeze

8.4d to cover

pts

Volume spike

Most-recent day's volume was >2× the 20-day average

–

pts

Type	Date	Insider	Title	Shares	Price	Value
Buy	2026-05-14	Wettig Thane	CEO	2,800	$7.09	$19.9K